Search Results for: "Clinic Roundup"
-
Clinic Roundup
Elcelyx Therapeutics Inc., of San Diego, said it is enrolling patients with Type II diabetes in a Phase IIb trial of NewMet, a delayed-release formulation of generic metforminBioWorld Today | Tuesday, May 21, 2013 -
Clinic Roundup
Pexa-Vec is currently being evaluated in an international, randomized Phase IIb trial (TRAVERSE) in patients with advanced primary liver cancer who have failed sorafenib therapyBioWorld Today | Thursday, May 16, 2013 -
Clinic Roundup
CytRx Corp., of Los Angeles, said the independent data safety monitoring committee overseeing the company's international Phase IIb trial with aldoxorubicin as a first-line treatment for patients with late-stage metastatic soft tissue sarcoma has recommended conducting the clinical trial through completion...Data from the Phase IIb trial is expected in the second half of 2013BioWorld Today | Tuesday, May 7, 2013 -
Clinic Roundup
Seaside Therapeutics Inc., of Cambridge, Mass., said its Phase IIb trial evaluating arbaclofen (STX209) in core impairments of autism spectrum disorder (ASD) failed to show improvement on the primary endpoint of social withdrawal but demonstrated improvement on the clinical global impression of severity scaleBioWorld Today | Friday, May 3, 2013 -
Clinic Roundup
Oxygen Biotherapeutics Inc., of Morrisville, N.C., said it initiated the second cohort of its Phase IIb trial of Oxycyte in patients with severe, nonpenetrating traumatic brain injury (TBIBioWorld Today | Wednesday, May 1, 2013 -
Clinic Roundup
Sorbent Therapeutics Inc., of Sunnyvale, Calif., began dosing patients in a Phase IIb trial (STEPWISE) of CLP-1001 in congestive heart failureBioWorld Today | Friday, April 12, 2013 -
Clinic Roundup
Ltd., of Seoul, South Korea, said they completed the Phase IIb trial of Tarafenacin, in development for treating overactive bladder syndromeBioWorld Today | Thursday, April 11, 2013 -
Clinic Roundup
NovaBay Pharmaceuticals Inc., of Emeryville, Calif., enrolled first patients in Brazil into its global Phase IIb trial, BAYnovationBioWorld Today | Tuesday, April 9, 2013 -
Clinic Roundup
Aastrom Biosciences Inc., of Ann Arbor, Mich., enrolled its first patients in a Phase IIb trial of ixCELL-DCM to assess safety and efficacy of ixmyelocel-T in advanced heart failure that is caused by ischemic dilated cardiomyopathy...Biogen Idec Inc., of Weston, Mass., said results of a daclizumab high-yield process (DAC HYP) Phase IIb trial were published online in The LancetBioWorld Today | Friday, April 5, 2013 -
Clinic Roundup
CureVac GmbH, of Tubingen, Germany, said it started a Phase IIb trial testing RNActive cancer vaccine CV9104 in patients with castration-resistant prostate cancer...Neurocrine Biosciences Inc., of San Diego, said it started a Phase IIb trial testing elagolix, an oral gonadotropin-releasing hormone antagonist, in uterine fibroidsBioWorld Today | Thursday, March 28, 2013 -
Clinic Roundup
Poxel SA, of Lyon, France, said it started a Phase IIb trial of imeglimin in Type II diabetesBioWorld Today | Friday, March 8, 2013 -
Clinic Roundup
Tobira Therapeutics Inc., of South San Francisco, reported results from a Phase IIb trial of cenicriviroc, a once-daily dual CCR5/CCR2 inhibitor, at the Conference on Retroviruses and Opportunistic Infections in AtlantaBioWorld Today | Wednesday, March 6, 2013 -
Clinic Roundup
Vintafolide and etarfolatide are currently being evaluated in a Phase III randomized, double-blind trial for platinum-resistant ovarian cancer (PROCEED trial) and a Phase IIb trial in patients with NSCLC (TARGET trial...Data from a Phase IIB trial were presented last week at the International Society for the Study of Women's Sexual Health conference in New OrleansBioWorld Today | Monday, March 4, 2013 -
Clinic Roundup
Data from a Phase IIb trial evaluating the safety and efficacy of tuberculosis (TB) vaccine MVA85A showed that a single dose of the vaccine was not sufficient to confer statistically significant protection against TB or infection in infants vaccinated at birth with the Bacille Calmette-Guérin (BCG) vaccineBioWorld Today | Tuesday, February 5, 2013 -
Clinic Roundup
CytRx Corp., of Los Angeles, said a data safety monitoring committee recommended continuing a Phase IIb trial of tamibarotene with chemotherapy in non-small-cell lung cancerBioWorld Today | Friday, February 1, 2013 -
Clinic Roundup
Molecular Partners licensed rights to MP0112 to Allergan Inc., of Irvine, Calif., which is testing the drug in a Phase IIb trial in exudative age-related macular degeneration. (See BioWorld Today, May 11, 2011BioWorld Today | Friday, January 18, 2013 -
Clinic Roundup
Synergy Pharmaceuticals Inc., of New York, said dosing has commenced in a Phase IIb trial of plecanatide to treat patients with constipation-predominant irritable bowel syndrome (IBS-CBioWorld Today | Friday, December 28, 2012 -
Clinic Roundup
Neurocrine Biosciences Inc., of San Diego, said it started a Phase IIb trial (Kinect 2 Study) of its vesicular monoamine transporter 2 compound, NBI-98854BioWorld Today | Thursday, December 20, 2012 -
Clinic Roundup
Pharmalink AB, of Stockholm, Sweden, began a Phase IIb trial of Nefecon (Nefigan) for IgA nephropathyBioWorld Today | Wednesday, December 19, 2012 -
Clinic Roundup
Celladon Corp., of San Diego, dosed its first patient in Europe in a Phase IIb trial of Mydicar for heart failureBioWorld Today | Thursday, December 13, 2012
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.